
Platikem 20mg Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Cisplatin (20mg)
Overview Platikem 20mg Injection
Cisplatin 20mg Injection, a prescription medication, treats ovarian, cervical, and testicular cancers. Its mechanism involves inhibiting or reducing the proliferation of cancerous cells. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may adjust over time. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue use only under your doctor's guidance. Common side effects include injection site inflammation (pain, swelling, redness), nausea, and vomiting. Serious side effects include auditory impairment, necessitating hearing assessments before and during therapy. The medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests monitor blood cell levels and kidney, liver, and heart function. Disclose any history of kidney disease to your doctor beforehand due to the medication's renal impact. Inform your healthcare provider about all other medications you are taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding. Male infertility is a potential risk; sperm banking should be considered prior to treatment initiation.
Uses of Platikem 20mg Injection
Cancers of the ovaries, cervix, and testes.
Major Benefits of Platikem 20mg Injection:
Administering this medication will be handled by your physician or their designated nurse; please refrain from self-medicating.
Common Side effects of Platikem 20mg Injection:
- Injection site reactions (pain, swelling, redness)
- Increased risk of infection
- Ear disorder
- Vomiting
- Nausea
- Decreased blood cells (red cells, white cells, and platelets)
- Renal impairment
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Kidney damage
- Hearing loss
- Ringing in ear
How to use Platikem 20mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Platikem 20mg Injection works:
Oncasin 20mg Injection is a chemotherapeutic agent. Its mechanism of action involves disrupting the genetic structure (DNA and RNA) of malignant cells, thereby inhibiting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Platikem 20mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Platikem 20mg Injection during pregnancy poses a confirmed risk to fetal development, and thus is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Platikem 20mg Injection while breastfeeding poses a significant risk. Evidence indicates potential infant harm due to the medication's toxicity.
DrivingUNSAFE
Administering Platikem 20mg Injection may induce adverse reactions, potentially impairing driving capabilities. These reactions can include drowsiness and/or nausea, impacting the ability to operate a vehicle safely.
KidneyCAUTION
Patients with kidney impairment should use Platikem 20mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Platikem 20mg Injection is contraindicated in those with severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of Platikem 20mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Platikem 20mg Injection :
Omitting a scheduled dose of Platikem 20mg Injection necessitates contacting your physician.
Facts to Know About Platikem 20mg Injection
| Label | Value |
|---|---|
| Type of Compound | Platinum-based compounds |
| Potential for Dependence | None. |
| Medication Classification | Cancer therapeutics |
| Mechanism of Action | Platinum-based anti-neoplastic agents |
